173 related articles for article (PubMed ID: 18854113)
1. Treatment of symptomatic uterine leiomyoma with letrozole.
Gurates B; Parmaksiz C; Kilic G; Celik H; Kumru S; Simsek M
Reprod Biomed Online; 2008 Oct; 17(4):569-74. PubMed ID: 18854113
[TBL] [Abstract][Full Text] [Related]
2. A randomized, controlled clinical trial comparing the effects of aromatase inhibitor (letrozole) and gonadotropin-releasing hormone agonist (triptorelin) on uterine leiomyoma volume and hormonal status.
Parsanezhad ME; Azmoon M; Alborzi S; Rajaeefard A; Zarei A; Kazerooni T; Frank V; Schmidt EH
Fertil Steril; 2010 Jan; 93(1):192-8. PubMed ID: 19135657
[TBL] [Abstract][Full Text] [Related]
3. Role of the aromatase inhibitor letrozole in the management of uterine leiomyomas in premenopausal women.
Duhan N; Madaan S; Sen J
Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):329-32. PubMed ID: 24103533
[TBL] [Abstract][Full Text] [Related]
4. Aromatase inhibitors for uterine fibroids.
Song H; Lu D; Navaratnam K; Shi G
Cochrane Database Syst Rev; 2013 Oct; (10):CD009505. PubMed ID: 24151065
[TBL] [Abstract][Full Text] [Related]
5. Action of aromatase inhibitor for treatment of uterine leiomyoma in perimenopausal patients.
Hilário SG; Bozzini N; Borsari R; Baracat EC
Fertil Steril; 2009 Jan; 91(1):240-3. PubMed ID: 18249392
[TBL] [Abstract][Full Text] [Related]
6. Three-month treatment with triptorelin, letrozole and ulipristal acetate before hysteroscopic resection of uterine myomas: prospective comparative pilot study.
Bizzarri N; Ghirardi V; Remorgida V; Venturini PL; Ferrero S
Eur J Obstet Gynecol Reprod Biol; 2015 Sep; 192():22-6. PubMed ID: 26142912
[TBL] [Abstract][Full Text] [Related]
7. Comparing the effect of aromatase inhibitor (letrozole) + cabergoline (Dostinex) and letrozole alone on uterine myoma regression,a randomized clinical trial.
Sayyah-Melli M; Mobasseri M; Gharabaghi PM; Ouladsahebmadarek E; Rahmani V
Eur J Obstet Gynecol Reprod Biol; 2017 Mar; 210():257-264. PubMed ID: 28076829
[TBL] [Abstract][Full Text] [Related]
8. Effect of the aromatase inhibitor anastrozole on uterine and leiomyoma Doppler blood flow in patients scheduled for hysterectomy: a pilot study.
Brito LG; Candido-dos-Reis FJ; Magario FA; Sabino-de-Freitas MM
Ultrasound Obstet Gynecol; 2012 Jul; 40(1):119-20. PubMed ID: 22102490
[No Abstract] [Full Text] [Related]
9. Preoperative treatment with letrozole in patients undergoing laparoscopic myomectomy of large uterine myomas: a prospective non-randomized study.
Leone Roberti Maggiore U; Scala C; Venturini PL; Ferrero S
Eur J Obstet Gynecol Reprod Biol; 2014 Oct; 181():157-62. PubMed ID: 25150954
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of a symptomatic uterine leiomyoma in a perimenopausal woman with a nonsteroidal aromatase inhibitor.
Shozu M; Murakami K; Segawa T; Kasai T; Inoue M
Fertil Steril; 2003 Mar; 79(3):628-31. PubMed ID: 12620453
[TBL] [Abstract][Full Text] [Related]
11. Oral Gonadotropin-Releasing Hormone Antagonist Relugolix Compared With Leuprorelin Injections for Uterine Leiomyomas: A Randomized Controlled Trial.
Osuga Y; Enya K; Kudou K; Tanimoto M; Hoshiai H
Obstet Gynecol; 2019 Mar; 133(3):423-433. PubMed ID: 30741797
[TBL] [Abstract][Full Text] [Related]
12. Treatment of uterine leiomyomata with a luteinizing hormone-releasing hormone agonist: the possibility of nonsurgical management in selected perimenopausal women.
Nakamura Y; Yoshimura Y; Yamada H; Ubukata Y; Ando M; Suzuki M
Fertil Steril; 1991 May; 55(5):900-5. PubMed ID: 1902420
[TBL] [Abstract][Full Text] [Related]
13. Two-step gonadotropin-releasing hormone agonist treatment of uterine leiomyomas: standard-dose therapy followed by reduced-dose therapy.
Broekmans FJ; Hompes PG; Heitbrink MA; Netelenbos CC; Roos JC; Falke TM; Schoemaker J
Am J Obstet Gynecol; 1996 Nov; 175(5):1208-16. PubMed ID: 8942490
[TBL] [Abstract][Full Text] [Related]
14. [Neoadjuvant use of the aromatase inhibitor letrozole in uterine cancer: endocrine and clinical effects].
Bershteĭn LM; Maksimov SIa; Gershfel'd ED; Gamaiunova VB; Tsyrlina EV; Meshkova IE; Kovalenko IG; Larionov AA; Kovalevskiĭ AIu; Vasil'ev DA
Vopr Onkol; 2001; 47(5):571-4. PubMed ID: 11785098
[TBL] [Abstract][Full Text] [Related]
15. An effective alternative to only gonadotrophin for controlled ovarian stimulation in unexplained infertility patients undergoing intra-uterine insemination: a clinical trial.
Chaudhury K; Chaudhury S; Khastgir G; Purakaystha S
J Indian Med Assoc; 2013 Sep; 111(9):589-92, 594. PubMed ID: 24968520
[TBL] [Abstract][Full Text] [Related]
16. Long-term administration of tibolone plus gonadotropin-releasing hormone agonist for the treatment of uterine leiomyomas: effectiveness and effects on vasomotor symptoms, bone mass, and lipid profiles.
Palomba S; Affinito P; Di Carlo C; Bifulco G; Nappi C
Fertil Steril; 1999 Nov; 72(5):889-95. PubMed ID: 10560995
[TBL] [Abstract][Full Text] [Related]
17. Associations between genetic variants and the effect of letrozole and exemestane on bone mass and bone turnover.
Oesterreich S; Henry NL; Kidwell KM; Van Poznak CH; Skaar TC; Dantzer J; Li L; Hangartner TN; Peacock M; Nguyen AT; Rae JM; Desta Z; Philips S; Storniolo AM; Stearns V; Hayes DF; Flockhart DA
Breast Cancer Res Treat; 2015 Nov; 154(2):263-73. PubMed ID: 26536870
[TBL] [Abstract][Full Text] [Related]
18. Effect of letrozole versus placebo on bone mineral density in women with primary breast cancer completing 5 or more years of adjuvant tamoxifen: a companion study to NCIC CTG MA.17.
Perez EA; Josse RG; Pritchard KI; Ingle JN; Martino S; Findlay BP; Shenkier TN; Tozer RG; Palmer MJ; Shepherd LE; Liu S; Tu D; Goss PE
J Clin Oncol; 2006 Aug; 24(22):3629-35. PubMed ID: 16822845
[TBL] [Abstract][Full Text] [Related]
19. The role of estrogen in the feedback regulation of follicle-stimulating hormone secretion in the female rat.
Bhatnagar AS; Batzl C; Häusler A; Nogués V
J Steroid Biochem Mol Biol; 1993 Dec; 47(1-6):161-6. PubMed ID: 8274431
[TBL] [Abstract][Full Text] [Related]
20. A case of benign metastasizing leiomyoma treated by surgical castration followed by an aromatase inhibitor, anastrozole.
Nasu K; Tsuno A; Takai N; Narahara H
Arch Gynecol Obstet; 2009 Feb; 279(2):255-7. PubMed ID: 18523791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
